Investment Summary |
|
|---|---|
| Date | 2005-05-01 |
| Target | Affimed Therapeutics AG |
| Sector | Life Science |
| Investor(s) | SHS |
| Deal Type | Growth Capital |
SEARCH BY
Try For Free 7-Day Free Trial
SHS is a private equity firm focused on the healthcare sector. Specific areas of interest include life science, medical technology, diagnostics, applied technologies, digital health, and industrial biotechnology. The Firm will consider opportunities at all company stages and looks to commit up to €30 million in businesses valued up to €100 million. Target geographies include Germany, Austria, Switzerland, Scandinavia, and Benelux. SHS was established in 1993 and is headquartered in Tubingen, Germany.
| DEAL STATS | # |
|---|---|
| Overall | 4 of 26 |
| Sector (Life Science) | 3 of 8 |
| Type (Growth Capital) | 3 of 15 |
| Country (Germany) | 4 of 17 |
| Year (2005) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2003-06-12 |
ProBioGen AG
Berlin, Germany ProBioGen AG optimization of mammalian cell lines for production and manufacturing of recombinant proteins. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2006-03-01 |
Acino
Zurich, Czech Republic Acino is a pharmaceutical company focused on developing, manufacturing and marketing well-proven and innovative pharmaceuticals in novel drug delivery forms. Acino was founded in 1836 and is based in Zurich, Czech Republic. |
Buy | - |
